Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T97071 | ||||
Target Name | Glutamate carboxypeptidase II (GCPII) | ||||
Type of Target |
Successful |
||||
Drug Potency against Target | 2-(2-carboxy-5-mercaptopentyl)benzoic acid | Drug Info | IC50 = 1700 nM | [3] | |
2-(2-carboxy-7-mercaptoheptyl)benzoic acid | Drug Info | IC50 = 190 nM | [3] | ||
2-(2-Hydroxycarbamoyl-ethyl)-pentanedioic acid | Drug Info | IC50 = 1200 nM | [2] | ||
2-(2-Mercapto-ethyl)-pentanedioic acid | Drug Info | IC50 = 580 nM | [1] | ||
2-(2-Phosphonooxy-ethyl)-pentanedioic acid | Drug Info | IC50 = 1200 nM | [1] | ||
2-(3-carbamoylbenzyl)-5-mercaptopentanoic acid | Drug Info | IC50 = 2200 nM | [3] | ||
2-(3-carboxybenzyl)succinic acid | Drug Info | IC50 = 15000 nM | [3] | ||
2-(3-cyanobenzyl)-5-mercaptopentanoic acid | Drug Info | IC50 = 1800 nM | [3] | ||
2-(3-Hydroxycarbamoyl-propyl)-pentanedioic acid | Drug Info | IC50 = 940 nM | [2] | ||
2-(3-Mercapto-propyl)-pentanedioic acid | Drug Info | IC50 = 90 nM | [1] | ||
2-(3-Methylsulfanyl-propyl)-pentanedioic acid | Drug Info | IC50 = 6500 nM | [1] | ||
2-(4-Mercapto-butyl)-pentanedioic acid | Drug Info | IC50 = 1100 nM | [1] | ||
2-(5-Mercapto-pentyl)-pentanedioic acid | Drug Info | IC50 = 2600 nM | [1] | ||
2-benzyl-5-mercaptopentanoic acid | Drug Info | IC50 = 1400 nM | [3] | ||
2-Hydroxycarbamoyl-pentanedioic acid | Drug Info | IC50 = 4000 nM | [2] | ||
2-Hydroxycarbamoylmethyl-pentanedioic acid | Drug Info | IC50 = 220 nM | [2] | ||
2-Mercapto-pentanedioic acid | Drug Info | IC50 = 2600 nM | [1] | ||
2-Mercaptomethyl-pentanedioic acid | Drug Info | IC50 = 6000 nM | [1] | ||
2-Phosphonooxy-pentanedioic acid | Drug Info | IC50 = 1400 nM | [1] | ||
2-PMPA | Drug Info | IC50 = 0.3 nM | [5] | ||
3-(1-carboxy-4-mercaptobutoxy)benzoic acid | Drug Info | IC50 = 14 nM | [3] | ||
3-(2-carbamoyl-5-mercaptopentyl)benzoic acid | Drug Info | IC50 = 640 nM | [3] | ||
3-(2-carboxy-3-mercaptopropyl)benzoic acid | Drug Info | IC50 = 440 nM | [3] | ||
3-(2-carboxy-3-phosphonopropyl)benzoic acid | Drug Info | IC50 = 120 nM | [3] | ||
3-(2-carboxy-4-mercaptobutyl)benzoic acid | Drug Info | IC50 = 1100 nM | [3] | ||
3-(2-carboxy-5-mercaptopentyl)benzoic acid | Drug Info | IC50 = 15 nM | [3] | ||
3-(2-carboxy-6-mercaptohexyl)benzoic acid | Drug Info | IC50 = 390 nM | [3] | ||
3-[(1-carboxy-4-mercaptobutyl)thio]benzoic acid | Drug Info | IC50 = 32 nM | [3] | ||
4-(2-carboxy-5-mercaptopentyl)benzoic acid | Drug Info | IC50 = 63 nM | [3] | ||
5-Mercapto-pentanoic acid | Drug Info | IC50 = 1400 nM | [1] | ||
[3H]quisqualate | Drug Info | IC50 = 9500 nM | [4] | ||
References | |||||
REF 1 | Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor. J Med Chem. 2003 May 8;46(10):1989-96. | ||||
REF 2 | Synthesis and biological evaluation of hydroxamate-Based inhibitors of glutamate carboxypeptidase II. Bioorg Med Chem Lett. 2003 Jul 7;13(13):2097-100. | ||||
REF 3 | Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1' side chain. J Med Chem. 2006 May 18;49(10):2876-85. | ||||
REF 4 | Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II. J Med Chem. 2007 Jul 12;50(14):3267-73. | ||||
REF 5 | Design and synthesis of a siderophore conjugate as a potent PSMA inhibitor and potential diagnostic agent for prostate cancer. Bioorg Med Chem. 2008 Feb 15;16(4):1648-57. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.